Liu Wenfeng, Huang Shun, Li Yonglian, Zhang Kun, Zheng Xi
School of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China.
International Healthycare Innovation Institute, Jiangmen, China.
Food Nutr Res. 2019 Apr 29;63. doi: 10.29219/fnr.v63.1516. eCollection 2019.
Glycyrrhizinic acid (GA), a major active ingredient enriched in the roots of licorice, possesses well-confirmed anti-inflammatory effects.
To evaluate the underlying mechanisms of GA against lipopolysaccharide (LPS)-induced chronic neuroinflammation and memory impairment.
We explored to investigate the effects of GA on neuroinflammation and memory impairment in an LPS-induced Alzheimer's mouse model.
Data of micro-PET/CT imaging and morris water maze test suggested that GA, when administrated orally, could reverse LPS-induced abnormalized glucose intake and metabolism in the brain and alleviate LPS-induced memory loss and cognitive defects in mice. Histological and immunohistochemical staining results revealed that GA treatment suppressed overexpressions of pro-inflammatory cytokines of IL-1 β and TNF-α in the brain of C57 mice by inhibiting toll-like receptor 4 (TLR4) signaling pathway activation.
Our findings suggest that GA may be a therapeutic agent for the treatment of neuroinflammation and cognitive impairment.
甘草酸(GA)是甘草根中富含的主要活性成分,具有公认的抗炎作用。
评估GA对抗脂多糖(LPS)诱导的慢性神经炎症和记忆障碍的潜在机制。
我们探索研究GA对LPS诱导的阿尔茨海默病小鼠模型中神经炎症和记忆障碍的影响。
微PET/CT成像和莫里斯水迷宫试验数据表明,口服GA可逆转LPS诱导的大脑葡萄糖摄取和代谢异常,并减轻LPS诱导的小鼠记忆丧失和认知缺陷。组织学和免疫组化染色结果显示,GA治疗通过抑制Toll样受体4(TLR4)信号通路激活,抑制C57小鼠脑中促炎细胞因子IL-1β和TNF-α的过度表达。
我们的研究结果表明,GA可能是治疗神经炎症和认知障碍的一种治疗药物。